Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study
C DeBattista, K Doghramji, MA Menza… - Journal of Clinical …, 2003 - psychiatrist.com
Background: Fatigue and sleepiness are primary symptoms of depression that may not
resolve with antidepressant therapy. Modafinil is a novel agent that has been shown to …
resolve with antidepressant therapy. Modafinil is a novel agent that has been shown to …
Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: A preliminary double-blind, placebo-controlled …
C DeBattista, K Doghramji… - Journal of Clinical …, 2003 - researchwithrutgers.com
Background: Fatigue and sleepiness are primary symptoms of depression that may not
resolve with antidepressant therapy. Modafinil is a novel agent that has been shown to …
resolve with antidepressant therapy. Modafinil is a novel agent that has been shown to …
Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study …
C DeBattista, K Doghramji, MA Menza… - The Journal of …, 2003 - europepmc.org
BACKGROUND: Fatigue and sleepiness are primary symptoms of depression that may not
resolve with antidepressant therapy. Modafinil is a novel agent that has been shown to …
resolve with antidepressant therapy. Modafinil is a novel agent that has been shown to …
Adjunct Modafinil for the Short-Term Treatment of Fatigue and Sleepiness in Patients With Major Depressive Disorder: A Preliminary Double-Blind, Placebo-Controlled …
C DeBattista, K Doghramji, MA Menza… - J Clin …, 2003 - legacy.psychiatrist.com
Background: Fatigue and sleepiness are primary symptoms of depression that may not
resolve with antidepressant therapy. Modafinil is a novel agent that has been shown to …
resolve with antidepressant therapy. Modafinil is a novel agent that has been shown to …
Adjunct Modafinil for the Short-Term Treatment of Fatigue and Sleepiness in Patients With Major Depressive Disorder: A Preliminary Double-Blind, Placebo-Controlled …
C DeBattista, K Doghramji, MA Menza… - J Clin …, 2003 - psychiatrist.com
Background: Fatigue and sleepiness are primary symptoms of depression that may not
resolve with antidepressant therapy. Modafinil is a novel agent that has been shown to …
resolve with antidepressant therapy. Modafinil is a novel agent that has been shown to …
Adjunct Modafinil for the Short-Term Treatment of Fatigue and Sleepiness in Patients With Major Depressive Disorder: A Preliminary Double-Blind, Placebo-Controlled …
C DeBattista, K Doghramji, MA Menza… - The Journal of …, 2003 - psycnet.apa.org
Background: Fatigue and sleepiness are primary symptoms of depression that may not
resolve with antidepressant therapy. Modafinil is novel agent that has been shown to …
resolve with antidepressant therapy. Modafinil is novel agent that has been shown to …
Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study
C DeBattista, K Doghramji… - The Journal of …, 2003 - pubmed.ncbi.nlm.nih.gov
Background Fatigue and sleepiness are primary symptoms of depression that may not
resolve with antidepressant therapy. Modafinil is a novel agent that has been shown to …
resolve with antidepressant therapy. Modafinil is a novel agent that has been shown to …
[引用][C] Adjunct modafinil for the short-term treatment of fatigue and sleepiness in Patients with major depressive disorder: A preliminary double-blind, placebo …
C DEBATTISTA, K DOGHRAMJI… - The Journal of …, 2003 - pascal-francis.inist.fr
Adjunct modafinil for the short-term treatment of fatigue and sleepiness in Patients with major
depressive disorder: A preliminary double-blind, placebo-controlled study CNRS Inist …
depressive disorder: A preliminary double-blind, placebo-controlled study CNRS Inist …